advertisement

Topcon

Abstract #100808 Published in IGR 23-1

National protocol for diagnosis and care of congenital aniridia: Summary for the attending physician

Bremond-Gignac D; Robert M; Daruich A; Borderie V; Chiambaretta F; Valleix S;
Journal Français d'Ophtalmologie 2022; 45: 647-652


Congenital aniridia is a rare panocular disease defined by a national diagnostic and care protocol (PNDS) validated by the HAS. In most cases, it is due to an abnormality in the PAX6 gene, located at 11p13. Aniridia is a potentially blinding autosomal dominant disease with high penetrance. The prevalence varies from 1/40,000 births to 1/96,000 births. Approximately one third of cases are sporadic. Ocular involvement includes complete or partial absence of iris tissue, corneal opacification with neovascularization, glaucoma, cataract, foveal hypoplasia, optic disc hypoplasia and ptosis. These ocular disorders coexist to varying degrees and progress with age. Congenital aniridia manifests in the first months of life as nystagmus, visual impairment and photophobia. A syndromic form such as WAGR syndrome, WAGRO syndrome (due to the risk of renal Wilms tumor) or Gillespie syndrome (cerebellar ataxia) must be ruled out. Systemic associations may include diabetes, due to expression of the PAX6 gene in the pancreas, as well as other extraocular manifestations. Initial assessment is best carried out in a referral center specialized in rare ophthalmologic diseases, with annual follow-up. The management of progressive ocular involvement must be both proactive and responsive, with medical and surgical management. Visual impairment and photophobia result in disability, leading to difficulties in mobility, movement, communication, learning, fine motor skills, and autonomy, with consequences in personal, school, professional, socio-cultural and athletic life. Medico-socio-educational care involves a multidisciplinary team. Disability rehabilitation must be implemented to prevent and limit situations of handicap in activities of daily living, relying on the Commission for the Rights and Autonomy of People with Disabilities (CDAPH) within the Departmental House of People with Disabilities (MDPH). The general practitioner coordinates multidisciplinary medical and paramedical care.

Service d'ophtalmologie, centre hospitalier universitaire Necker-Enfants Malades, AP-HP, université de Paris, 149, rue de Sèvres, 75015 Paris, France; Inserm 1138, T17, université de Paris, Paris, France; OPHTARA, Coordonnateur centre de maladies rares en ophtalmologie (CRMR), Filière Sensgene, centre hospitalier universitaire Necker-Enfants Malades, Paris, France. Electronic address: dominique.bremond@aphp.fr.

Full article

Classification:

15 Miscellaneous



Issue 23-1

Change Issue


advertisement

Oculus